Page breadcrumb nav

VAERS Report 2156921

Case Report Section

Détails du rapport Vaer

Âge: 41 ans

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: 3005688


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-12-19
Date d’apparition
5
Nombre de jours (date d’apparition – date de vaccination)
5
Description de l’événement indésirable

shoulder pain; altered sensation; sars-cov-2 infection; frozen shoulder exacerbated; this case was received via the regulatory authority ra (reference number: gb-mhra-adr 26655725) on 27-feb-2022 and was forwarded to moderna on 27-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of arthralgia (shoulder pain), paraesthesia (altered sensation), covid-19 (sars-cov-2 infection) and periarthritis (frozen shoulder exacerbated) in a 41-year-old male patient who received mrna-1273 (moderna covid-19 vaccine) (batch no. 3005688) for an unknown indication. concomitant products included cortisone, covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) from 15-mar-2021 to an unknown date and covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) for an unknown indication. on 19-dec-2021, the patient received third dose of mrna-1273 (moderna covid-19 vaccine) (unknown route) 1 dosage form. on 24-dec-2021, the patient experienced periarthritis (frozen shoulder exacerbated) (seriousness criterion disability). on 29-dec-2021, the patient experienced covid-19 (sars-cov-2 infection) (seriousness criterion disability). on an unknown date, the patient experienced arthralgia (shoulder pain) (seriousness criterion disability) and paraesthesia (altered sensation) (seriousness criterion disability). on 03-jan-2022, covid-19 (sars-cov-2 infection) had resolved. at the time of the report, arthralgia (shoulder pain) and paraesthesia (altered sensation) was resolving and periarthritis (frozen shoulder exacerbated) had not resolved. diagnostic results (normal ranges are provided in parenthesis if available): on 28-dec-2021, sars-cov-2 test: yes - positive covid-19 test yes - positive covid-19 test. the action taken with mrna-1273 (moderna covid-19 vaccine) (unknown) was unknown. event started with acute shoulder pain on 24th dec which continued to get worse, swelling and spasm followed with pain through the shoulder blade down to the hand. this was followed by altered sensation and subsequent power loss to the shoulder and upper arm. repeated doctors appointments with significant medication prescribed which was largely ineffective. cortisone injection into the shoulder joint on 10/01/2022 which was also ineffective. this resulted in being off work for 5 weeks and was still a significant unresolved problem. patient was not enrolled in clinical trial. this report was not related to possible inflammation of the heart (myocarditis or pericarditis). details of any relevant investigations or tests conducted: mri scan on 01/02/2022. company comment: this is a regulatory authority case concerning a 41-year-old male patient, with no medical history reported, who experienced the unexpected and serious (disability) events of arthralgia, paraesthesia, covid-19 (adr), and periarthritis (adr). the events occurred between 5 and 10 days after the third dose of mrna-1273 vaccine. primary vaccination against covid-19 completed with astrazeneca vaccine (interchange of vaccine products). patient reports having received cortisone injection into shoulder joint, which was ineffective; this resulted in being off work for 5 weeks, and is still a significant unresolved problem. an mri scan was performed, with unknown result. sars-cov-2 test positive. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report.; sender's comments: this is a regulatory authority case concerning a 41-year-old male patient, with no medical history reported, who experienced the unexpected and serious (disability) events of arthralgia, paraesthesia, covid-19 (adr), and periarthritis (adr). the events occurred between 5 and 10 days after the third dose of mrna-1273 vaccine. primary vaccination against covid-19 completed with astrazeneca vaccine (interchange of vaccine products). patient reports having received cortisone injection into shoulder joint, which was ineffective; this resulted in being off work for 5 weeks, and is still a significant unresolved problem. an mri scan was performed, with unknown result. sars-cov-2 test positive. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report

Données de laboratoire
test date: 20211228; test name: covid-19 virus test; result unstructured data: yes - positive covid-19 test
Liste des symptômes
paraesthesia arthralgia periarthritis covid-19 sars-cov-2 test
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Oui
Allergies:
na
Maladie actuelle
na